Prospective Study of Induction Medications Used in the Trauma RSI
Withdrawn before enrolling
Conditions studied: Trauma, Rapid Sequence Intubation
In brief
To compare the outcomes of the use of propofol, etomidate, and ketamine as induction agents for adult trauma patients undergoing intubation within 24 hours of admission. The primary goal is to determine the ideal agent that should be used in this patient population for intubations.
Key facts
- Study ID
- NCT04291521
- Run by
- University of Southern California
- People needed
- 0
- Starts
- 2027-01-01
- Expected to finish
- 2029-07-30
- Last updated by the study team
- 2026-05-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Trauma patients >=18 yo requiring intubation within 24 hours of admission in either the ED or OR
- Patients received propofol, etomidate, or ketamine for induction agent
You may not qualify if…
- Patients who were intubated without induction agent medications
- Patients intubated outside of the hospital or in the field
- Patients who were intubated with an induction agent other than etomidate, ketamine, or propofol
Where it is running
- Keck School of Medicine of the University of Southern California — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.